Buy or sell Genapsys stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Genapsys Stock

GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.



Total Funding


About Genapsys Stock

GenapSys, Inc. is committed to a new era of applied genomic testing and a new paradigm for medical sequencing. We are developing a cost-disruptive, easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology which delivers 100x improvement in cost and speed. These innovations will enable a new era of medicine through the widespread acquisition of genomic data for research and testing of genetic disease, cancer, and microbes.

Funding History

May 2012$0
March 2013$8.5M
November 2013$37.0M


Head of Talent & Happiness

Diana Kofman

Director of Nanofabrication

Kosar Parizi

Director of Business Development

Avaleigh Milne

Senior Director & Head of Europe

Leila Zegna

Director of Sequencing

Xavier Gomes

Leads Strategic Initiatives

Howard Goldstein

VP of Product Development

Subra Sankar

VP Engineering

Hamid Rategh

Director of Product & Test Engineering

Ashok Ramachandran

Director of Chemistry

Aldrich Lau


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: